An unusual suspect is leading Wednesday's market while the AI trade takes a breather

U.S. equities are posting modest gains on Wednesday, with the S&P 500 nearing a record close, primarily driven by a rebound in the healthcare sector, notably Eli Lilly following significant insider purchases by executives after a recent selloff. Conversely, AI infrastructure and chip stocks, including Nvidia and Broadcom, are experiencing a pullback. This coincides with newly public CoreWeave's unchanged full-year capital expenditure guidance, which, despite implying a substantial Q4 ramp, signals capacity limitations due to power availability rather than a softening in robust AI demand.

Analysis

U.S. equity markets are exhibiting signs of a sector rotation, with the S&P 500 trading near a record high, driven by a rebound in the healthcare sector. This sector, despite a more than 1% gain on the day, remains down over 3.5% year-to-date, positioning it as a laggard play. The advance is notably led by Eli Lilly (LLY), which is rallying following a series of significant insider buy transactions by its CEO and Chief Scientific Officer. This executive buying action follows a recent stock selloff triggered by disappointing trial data and signals a strong degree of internal confidence. In contrast, the previously high-flying AI infrastructure cohort, including Nvidia (NVDA) and Broadcom (AVGO), is experiencing a pullback. This move coincides with the earnings outlook from CoreWeave (CRWV), which maintained its full-year capital expenditure guidance at $20 billion to $23 billion. While this may have been interpreted as a sign of slowing growth, it implies a substantial ramp in Q4 spending, with the primary constraint being power availability, not a weakening of AI demand, which reportedly continues to exceed supply. Investors are now looking ahead to Cisco's (CSCO) earnings for further confirmation of AI infrastructure order momentum.

Key Decisions for Investors

• Consider the significant insider buying at Eli Lilly as a strong vote of confidence from management, potentially creating a tactical entry point following the recent data-driven selloff.
• Evaluate the current pullback in AI infrastructure stocks as a potential opportunity, recognizing that CoreWeave's guidance suggests the bottleneck is physical capacity and power availability, not a deterioration in underlying demand.
• Monitor the ongoing sector rotation from high-momentum AI names into undervalued sectors like healthcare, and watch upcoming catalysts like Cisco's earnings and producer price index data to gauge the durability of this market shift.